关注
Paolo Ricchi
Paolo Ricchi
Malattie Rare del Globulo Rosso, AORN Cardarelli, Napoli, Italia
在 aocardarelli.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy
P Ricchi, R Zarrilli, A Di Palma, AM Acquaviva
British journal of cancer 88 (6), 803-807, 2003
1812003
IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells
A Di Popolo, A Memoli, A Apicella, C Tuccillo, A di Palma, P Ricchi, ...
Oncogene 19 (48), 5517-5524, 2000
1322000
PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation
V Leone, A di Palma, P Ricchi, F Acquaviva, M Giannouli, AM Di Prisco, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 293 (4 …, 2007
1182007
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix
S Pignata, G Silvestro, E Ferrari, L Selvaggi, F Perrone, A Maffeo, ...
Journal of clinical oncology 17 (3), 756-756, 1999
991999
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
C Borgna‐Pignatti, MC Garani, GL Forni, MD Cappellini, E Cassinerio, ...
British journal of haematology 167 (1), 121-126, 2014
972014
Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco‐2 cells
P Ricchi, S Pignata, A Di Popolo, A Memoli, A Apicella, R Zarrilli, ...
International journal of cancer 73 (6), 880-884, 1997
871997
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or …
A Pepe, A Meloni, G Rossi, L Cuccia, GD D'Ascola, M Santodirocco, ...
Journal of Cardiovascular Magnetic Resonance 15 (1), 1, 2013
732013
Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri
S Pignata, P Frezza, S Tramontana, F Perrone, R Tambaro, G Casella, ...
Annals of oncology 11 (4), 455-459, 2000
662000
Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma
S Pignata, B Daniele, MG Galati, G Esposito, P Vallone, F Fiore, P Ricchi, ...
European journal of gastroenterology & hepatology 9 (3), 283-286, 1997
621997
Using fuzzy logic for improving clinical daily-care of β-thalassemia patients
S Santini, A Pescapè, AS Valente, V Abate, G Improta, M Triassi, P Ricchi, ...
2017 IEEE international conference on fuzzy systems (FUZZ-IEEE), 1-6, 2017
522017
Involvement of Akt/NF‐κB pathway in N6‐isopentenyladenosine‐induced apoptosis in human breast cancer cells
C Laezza, AM Malfitano, T Di Matola, P Ricchi, M Bifulco
Molecular carcinogenesis 49 (10), 892-901, 2010
412010
Aspirin protects Caco-2 cells from apoptosis after serum deprivation through the activation of a phosphatidylinositol 3-kinase/AKT/p21Cip/WAF1pathway
P Ricchi, A Di Palma, T Di Matola, A Apicella, R Fortunato, R Zarrilli, ...
Molecular pharmacology 64 (2), 407-414, 2003
412003
Effect of splenectomy on iron balance in patients with β‐thalassemia major: a long‐term follow‐up
M Casale, P Cinque, P Ricchi, S Costantini, A Spasiano, L Prossomariti, ...
European Journal of Haematology 91 (1), 69-73, 2013
402013
MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine
A Pepe, A Meloni, L Pistoia, L Cuccia, MR Gamberini, R Lisi, DG D'Ascola, ...
British Journal of Haematology 183 (5), 783-795, 2018
382018
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
AT Taher, MD Cappellini, A Kattamis, E Voskaridou, S Perrotta, AG Piga, ...
The Lancet Haematology 9 (10), e733-e744, 2022
362022
Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study
P Ricchi, M Ammirabile, A Spasiano, S Costantini, P Cinque, T Di Matola, ...
European journal of haematology 85 (1), 36-42, 2010
352010
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II
R Russo, I Andolfo, F Manna, G De Rosa, L De Falco, A Gambale, ...
Blood, The Journal of the American Society of Hematology 128 (14), 1899-1902, 2016
342016
A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients …
P Ricchi, M Ammirabile, S Costantini, T Di Matola, R Verna, A Diano, ...
Annals of hematology 91, 905-909, 2012
322012
Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients
P Ricchi, M Ammirabile, A Spasiano, S Costantini, T Di Matola, P Cinque, ...
European journal of haematology 82 (3), 219-222, 2009
322009
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia
KM Musallam, A Vitrano, A Meloni, SA Pollina, M Karimi, A El-Beshlawy, ...
Haematologica 106 (9), 2489, 2021
312021
系统目前无法执行此操作,请稍后再试。
文章 1–20